Grammer, T. B.; Kleber, M. E.; Silbernagel, Günther; Pilz, S.; Scharnagl, H.; Lerchbaum, E.; Tomaschitz, A.; Koenig, W.; März, W. (2014). Copper, ceruloplasmin, and long-term cardiovascular and total mortality (the Ludwigshafen Risk and Cardiovascular Health Study). Free radical research, 48(6), pp. 706-715. Informa Healthcare 10.3109/10715762.2014.901510
Full text not available from this repository.BACKGROUND
Copper and its main transport protein ceruloplasmin have been suggested to promote the development of atherosclerosis. Most of the data come from experimental and animal model studies. Copper and mortality have not been simultaneously evaluated in patients undergoing coronary angiography.
METHODS AND RESULTS
We examined whether serum copper and ceruloplasmin concentrations are associated with angiographic coronary artery disease (CAD) and mortality from all causes and cardiovascular causes in 3253 participants of the Ludwigshafen Risk and Cardiovascular Health Study. Age and sex-adjusted hazard ratios (HR) for death from any cause were 2.23 (95% CI, 1.85-2.68) for copper and 2.63 (95% CI, 2.17-3.20) for ceruloplasmin when we compared the highest with the lowest quartiles. Corresponding hazard ratios (HR) for death from cardiovascular causes were 2.58 (95% CI, 2.05-3.25) and 3.02 (95% CI, 2.36-3.86), respectively. Further adjustments for various risk factors and clinical variables considerably attenuated these associations, which, however, were still statistically significant and the results remained consistent across subgroups.
CONCLUSIONS
The elevated concentrations of both copper and ceruloplasmin are independently associated with increased risk of mortality from all causes and from cardiovascular causes.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Silbernagel, Günther |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1071-5762 |
Publisher: |
Informa Healthcare |
Language: |
English |
Submitter: |
Catherine Gut |
Date Deposited: |
13 Oct 2014 12:09 |
Last Modified: |
05 Dec 2022 14:35 |
Publisher DOI: |
10.3109/10715762.2014.901510 |
PubMed ID: |
24605902 |
URI: |
https://boris.unibe.ch/id/eprint/54455 |